Arun Ravindran

1995–2026 年に発表

135
論文数
18,805
被引用数
66
h 指数
101
i10 指数

被引用数

Arun Ravindran の年別被引用数1975 年: 被引用 1 件1995 年: 被引用 1 件1997 年: 被引用 4 件1998 年: 被引用 2 件1999 年: 被引用 15 件2000 年: 被引用 22 件2001 年: 被引用 34 件2002 年: 被引用 42 件2003 年: 被引用 37 件2004 年: 被引用 35 件2005 年: 被引用 58 件2006 年: 被引用 53 件2007 年: 被引用 47 件2008 年: 被引用 57 件2009 年: 被引用 115 件2010 年: 被引用 81 件2011 年: 被引用 78 件2012 年: 被引用 101 件2013 年: 被引用 92 件2014 年: 被引用 75 件2015 年: 被引用 105 件2016 年: 被引用 151 件2017 年: 被引用 105 件2018 年: 被引用 135 件2019 年: 被引用 498 件2020 年: 被引用 646 件2021 年: 被引用 549 件2022 年: 被引用 537 件2023 年: 被引用 465 件2024 年: 被引用 757 件2025 年: 被引用 328 件2026 年: 被引用 30 件1976〜1994 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,451 件、この内訳の 18.8%カナダ: 引用元論文 899 件、この内訳の 11.7%中国: 引用元論文 648 件、この内訳の 8.4%イギリス: 引用元論文 524 件、この内訳の 6.8%オーストラリア: 引用元論文 345 件、この内訳の 4.5%ドイツ: 引用元論文 324 件、この内訳の 4.2%イタリア: 引用元論文 322 件、この内訳の 4.2%スペイン: 引用元論文 284 件、この内訳の 3.7%ブラジル: 引用元論文 220 件、この内訳の 2.9%オランダ: 引用元論文 209 件、この内訳の 2.7%フランス: 引用元論文 172 件、この内訳の 2.2%日本: 引用元論文 149 件、この内訳の 1.9%
0%18.8%その他 28%

分野

  • Medicine55%
  • Neuroscience20.5%
  • Psychology11.8%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Computer Science3.1%
  • Engineering1.6%
  • その他4.4%

トピック

  • Treatment of Major Depression9.5%
  • Bipolar Disorder and Treatment7.1%
  • Tryptophan and brain disorders7%
  • Schizophrenia research and treatment3.9%
  • Electroconvulsive Therapy Studies3.3%
  • Stress Responses and Cortisol3%
  • その他66.2%

共著者

全論文

検索で開く
  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Bipolar Disorders 2018 被引用: 1,770

  2. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies

    著者: , , , , , , , , , , , , - Molecular Psychiatry 2019 被引用: 870

  3. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    著者: , , , , , , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 被引用: 1,123

  4. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

    著者: , , , , , , , , , , , , , , , , , - The International Journal of Neuropsychopharmacology 2019 被引用: 590

  5. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2016 被引用: 737

  6. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    著者: , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 被引用: 583

  7. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Berk - The World Journal of Biological Psychiatry 2022 被引用: 198

  8. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 被引用: 351

  9. Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce

    著者: , , , , , , , , , , , , , , , - The World Journal of Biological Psychiatry 2022 被引用: 158

  10. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents

    著者: , , , , , , , , , , , , , , - Molecular Psychiatry 2018 被引用: 181

  11. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update

    著者: , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2023 被引用: 104

  12. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kathryn Schade, Ayal Schaffer, Mark Sinyor, Cláudio N. Soares, Jennifer Swainson, Valerie H. Taylor, Smadar Valérie Tourjman, Rudolf Uher, Michael Van Ameringen, Gustavo Vázquez, Simone N. Vigod, Daphne Voineskos, Lakshmi N. Yatham, Roumen Milev - The Canadian Journal of Psychiatry 2024 被引用: 303

  13. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    著者: , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 被引用: 578

  14. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur

    著者: , , , , , , , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2020 被引用: 108

  15. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    著者: , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 被引用: 296

  16. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    著者: , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 被引用: 331

  17. GenSQLi: A Generative Artificial Intelligence Framework for Automatically Securing Web Application Firewalls Against Structured Query Language Injection Attacks

    著者: , - Future Internet 2024 被引用: 23

  18. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    著者: , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 被引用: 250

  19. Depression, Anxiety, and Other Mental Disorders in Patients With Cancer in Low- and Lower-Middle–Income Countries: A Systematic Review and Meta-Analysis

    著者: , , , - JCO Global Oncology 2021 被引用: 100

  20. Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis

    著者: , , , , , , , , , , - The International Journal of Neuropsychopharmacology 2015 被引用: 196

  21. Mez: An Adaptive Messaging System for Latency-Sensitive Multi-Camera Machine Vision at the IoT Edge

    著者: , , , - IEEE Access 2021 被引用: 71

  22. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder

    著者: , , , , , , , , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2022 被引用: 56

  23. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - 2019 被引用: 219

  24. Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies: Usage du cannabis et association prospective à long terme avec l’anxiété: une revue systématique et une méta-analyse d’études longitudinales

    著者: , , , - The Canadian Journal of Psychiatry 2020 被引用: 60